PZVNX | VIHAX | PZVNX / VIHAX | |
Total Expense Ratio | 1.09 | 0.17 | 641% |
Annual Report Gross Expense Ratio | 1.34 | 0.17 | 788% |
Fund Existence | 4 years | 10 years | - |
Gain YTD | 27.083 | 25.865 | 105% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 3000 | 167% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 120M | 13.4B | 1% |
Annual Yield % from dividends | 2.30 | 3.95 | 58% |
Returns for 1 year | 16.88 | 18.56 | 91% |
Returns for 3 years | 77.01 | 63.45 | 121% |
Returns for 5 years | N/A | 69.66 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QTOP | 31.31 | 0.22 | +0.71% |
iShares Nasdaq Top 30 Stocks ETF | |||
EQWL | 114.93 | 0.80 | +0.70% |
Invesco S&P 100 Equal Weight ETF | |||
LABD | 32.34 | 0.16 | +0.50% |
Direxion Daily S&P Biotech Bear 3X ETF | |||
BSJT | 21.54 | 0.04 | +0.19% |
Invesco BulletShares 2029 HY Corp Bd ETF | |||
ANEW | 51.26 | N/A | N/A |
ProShares MSCI Trnsfmtnl Chngs ETF |